Diego A. Díaz-García, Medical Oncologist /CEO/Founder at CánCare – High Specialty in Oncology and Medical Oncologist at Angeles del Carmen Hospital, shared a post on X:
“Wearables in Clinical Trials.
Wearables enable continuous, real-world endpoints in trials. In 1,021 studies (2001–2025), key roles include drug effects, dosing, adherence and delivery optimization. Adhesive patches lead adoption.
Regulatory qualification remains limited; SV95C is the only example. Validation and standardization are critical gaps.”
Title: Wearable technologies in clinical trials for drug development: trends and emerging opportunities
Authors: Zahi A. Fayad, Robert P. Hirten, Girish N. Nadkarni, Yun Soung Kim
Read the Full Article.
Other articles featuring Diego A. Díaz-García.